PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Eur J Clin Nutr. Author manuscript; available in PMC 2011 August 1.
Published in final edited form as:
PMCID: PMC3078753
NIHMSID: NIHMS220488

Lipid-soluble vitamins A, D, and E in HIV-infected pregnant women in Tanzania

Abstract

Background/Objectives

There is limited published research examining lipid-soluble vitamins in human immunodeficiency virus (HIV)-infected pregnant women, particularly in resource-limited settings.

Subjects/Methods

This is an observational analysis of 1078 HIV-infected pregnant women enrolled in a trial of vitamin supplementation in Tanzania. Baseline data on sociodemographic and anthropometric characteristics, clinical signs and symptoms, and laboratory parameters were used to identify correlates of low plasma vitamin A (<0.7 μmol/l), vitamin D (<80 nmol/l) and vitamin E (<9.7 μmol/l) status. Binomial regression was used to estimate risk ratios and 95% confidence intervals.

Results

Approximately 35, 39 and 51% of the women had low levels of vitamins A, D and E, respectively. Severe anemia (hemoglobin <85 g/l; P<0.01), plasma vitamin E (P=0.02), selenium (P=0.01) and vitamin D (P=0.02) concentrations were significant correlates of low vitamin A status in multivariate models. Erythrocyte Sedimentation Rate (ESR) was independently related to low vitamin A status in a nonlinear manner (P=0.01). The correlates of low vitamin D status were CD8 cell count (P=0.01), high ESR (ESR >81 mm/h; P<0.01), gestational age at enrollment (nonlinear; P=0.03) and plasma vitamins A (P=0.02) and E (P=0.01). For low vitamin E status, the correlates were money spent on food per household per day (P<0.01), plasma vitamin A concentration (nonlinear; P<0.01) and a gestational age <16 weeks at enrollment (P<0.01).

Conclusions

Low concentrations of lipid-soluble vitamins are widely prevalent among HIV-infected women in Tanzania and are correlated with other nutritional insufficiencies. Identifying HIV-infected persons at greater risk of poor nutritional status and infections may help inform design and implementation of appropriate interventions.

Keywords: HIV, AIDS, pregnancy, Africa, vitamins

Introduction

There is limited evidence on the status of lipid-soluble vitamins (A, D and E) in human immunodeficiency virus (HIV)-infected pregnant women, particularly in resource-limited settings. In HIV-uninfected pregnant women, vitamin deficiencies have been shown to lead to intrauterine growth retardation and adverse pregnancy outcomes such as preeclampsia, premature rupture of membranes, preterm delivery and low birth weight (Chappell et al., 1999; Stoltzfus and Humphrey, 2002). Moreover, maternal deficiencies in these nutrients are likely to affect breast milk composition and infant growth and development (Stoltzfus and Humphrey, 2002). Nutrient requirements are much higher during pregnancy to support maternal metabolism, infant growth and development, and physiological and hormonal adaptations (Picciano, 2003). Further, HIV-infected pregnant women are more likely to have several nutritional deficiencies and are at increased risk of adverse pregnancy outcomes (Fawzi, 2003).

Vitamin A deficiency during pregnancy is widely prevalent in developing countries, particularly in sub-Saharan Africa, and among HIV-infected women (Ahmed et al., 2003; Keverenge-Ettyang et al., 2006; Zvandasara et al., 2006); it may affect fetal development and risk of maternal morbidity and mortality (Stoltzfus and Humphrey, 2002). Further, infants depend on breast milk to obtain adequate vitamin A (Allen, 2006); vitamin A deficiency during childhood is associated with severe morbidity and mortality (Fawzi et al., 1993).

Vitamin D is essential for calcium metabolism and fetal skeletal development, with 25–30 g of calcium transferred to the fetus during pregnancy (Specker, 2004). Vitamin D also may be involved in development of the fetal immune system (Reichrath and Querings, 2005; Evans et al., 2006) and may protect against Type I diabetes mellitus (Stene et al., 2000).

As an antioxidant, vitamin E may minimize oxidative stress in the syncytiotrophoblast and prevent early pregnancy failure and preeclampsia (Di Renzo et al., 2005). Vitamin E also may have a role in the prevention of birth defects (Loeken, 2004) by reduction of oxygen free radicals. Maternal vitamin E concentrations have also been correlated with increased fetal growth and decreased risk of small-for-gestational-age births (Scholl et al., 2006).

Given the importance of these vitamins in pregnancy, identification of correlates of vitamin status may help inform appropriate targeted interventions. In this paper, we examined correlates of low vitamins A, D and E status at baseline (12–27 weeks gestation) assessment in a randomized trial of vitamin supplementation in HIV-infected pregnant women in Tanzania.

Methods

Study population

Study participants were HIV-infected pregnant women enrolled between 12 and 27 weeks of gestation in a randomized trial of vitamin supplementation, which has previously been described in detail (Fawzi et al., 1999). The study protocol was approved by the research and publications committee of the Muhimbili University College of Health Sciences, the ethical committee of the National AIDS Control Program of the Tanzanian Ministry of Health and the institutional review board of the Harvard School of Public Health.

Assessment of baseline covariates

Structured interviews were conducted during the baseline visit to collect information on obstetric history and demographic characteristics, including age, educational level and money spent on food daily. Data were also collected on history of morbidities, symptoms and hospitalizations during the current pregnancy. Gestational age was based on self-reported date of last menstrual period. Study physicians conducted a complete medical examination and collected blood, urine, stool and vaginal swab specimens. HIV disease stage was classified in accordance with the World Health Organization (WHO) guidelines (WHO, 1993). Anthropometric measurements, including weight, height and mid-upper arm circumference, were obtained by trained research assistants using standardized procedures and calibrated instruments.

Laboratory methods

Total leukocyte counts were performed with a CBC5 Coulter Counter (Coulter Corporation, Miami, FL, USA); differential white cell counts were evaluated manually. Absolute CD3, CD4 and CD8 T-cell counts were determined with the FACSCount system (Becton Dickinson, San Jose, CA, USA). Hemoglobin levels were assessed using a CBC5 Coulter Counter (Coulter Corporation) or the cyanmethemoglobin method with colorimeter (Corning Inc., Corning, NY, USA). HIV-1 serostatus was determined by the Enzygnost anti-HIV-1/2 Plus (Dade Behring, Marburg, Germany) followed by the Wellcozyme HIV-1 recombinant test (Murex Biotech Ltd, Dartford, UK) and the discordant results were resolved through western blot analysis (Bio-Rad Laboratories Ltd, Hertfordshire, UK) (Urassa et al., 1994). Selenium concentration was measured in plasma using neutron activation analysis and was adjusted for the sodium concentration of the sample, which is tightly regulated physiologically, to account for the degree of concentration or dilution of the sample (Kupka et al., 2005).

Sera and genital swabs were collected to identify sexually transmitted infections and malaria parasites were identified in thick smear blood films stained with giemsa. Stool specimens were examined to identify intestinal helminths (hookworm, Trichuris trichiura, Ascaris lumbricoides, Strongyloides stercoralis, Schistosoma mansoni) and pathogenic protozoan (Giardia lamblia, Entamoeba histolytica and Cryptosporidium parvum) infections. Urine samples were examined for presence of S. haematobium. Sexually transmitted infections, intestinal parasitic infections and malaria were treated at the time of diagnosis according to the Tanzanian Ministry of Health standards of care.

Assessment of outcome and outcome definitions

Blood samples were obtained at baseline, and plasma was stored at or below −70 °C. Measurements of baseline plasma vitamins A and E concentrations were carried out using reversed-phase high-performance liquid chromatography in a modification of the method of Zaman et al. (1993). Maternal vitamin D status was assessed using serum levels of 25-hydroxyvitamin D (25(OH)D). Serum 25(OH)D levels were measured by the fully automated chemiluminescence ADVANTAGE 25(OH)D assay system obtained from Nichols Institute Diagnostics (San Juan Capistrano, CA, USA). Vitamin A deficiency was defined as <0.7 μmol/l, as per conventional criteria (de Pee and Dary, 2002); low vitamin E status was defined according to the study population median (<9.7 μmol/l), as consistent with previous publications from this trial. The cutoff for low vitamin D status was serum 25(OH)D <80 nmol/l, which is considered optimal for calcium homeostasis (Holick, 2004).

Statistical analyses

Sociodemographic factors considered in the analysis included age, literacy level and occupation of women; source of income support; average household income; marital status and pregnancy history. Maternal weight, height and mid-upper arm circumference were examined as continuous variables. Conventional cutoffs were used to categorize predictors where available; otherwise, median values were used to classify variables, as consistent with previous publications from this trial (Antelman et al., 2001). Body mass index (kg/m2) was categorized according to WHO standards (WHO, 1995). Anemia was defined as hemoglobin <110 g/l and severe anemia as hemoglobin <85 g/l. CD4 counts were categorized as <200, 200–499 or ≥500 cells per μl; and CD8 and CD3 counts were classified according to their median values. Malaria parasitemia was categorized as light (1–999 per μl), moderate (1000–9999 per μl) or heavy (≥10 000 per μl), respectively.

Risk ratios and 95% confidence intervals were estimated by binomial regression with the log-link function. When the log-binomial model failed to converge, log-Poisson models—which provide consistent, but not fully efficient, estimates of the risk ratio and its confidence intervals—were used (Spiegelman and Hertzmark, 2005). Variables with univariate P-values <0.20 were included in multivariate regression models and retained if their P-values were <0.05. Potential nonlinear relationships between covariates and outcomes were examined nonparametrically with stepwise restricted cubic splines (Durrleman and Simon, 1989; Govindarajulu et al., 2007). Tests for nonlinearity used the likelihood ratio test, comparing the model with only the linear term to the model with the linear and the cubic spline terms. When a nonlinear relationship was found, restricted cubic spline variables were created and entered into the binomial regression model. Observations with missing data for covariates were retained using the missing indicator method for variables missing >1% of observations (Miettinen, 1985). Statistical analyses were performed using SAS software version 9.2 (SAS Institute Inc., Cary, NC, USA).

Results

Baseline characteristics of the study population are presented in Table 1. The average age (±s.d.) of study participants was 24.7 (±4.8) years. Most (92%) women were literate and over 70% described their occupation as housewife. The averagege stational age at randomization was 20.4 (±3.4) weeks and more than one-third of women were primiparous. 83% of women were anemic (<110 g/l) and 27% were severely anemic (<85 g/l) at baseline. Approximately 85% of women had stage I HIV disease, and 12% had CD4 cell counts <200 cells per μl. Plasmodium falciparum malaria parasitemia was prevalent in 19% of participants.

Table 1
Baseline characteristics of women enrolled in the trial (N = 1077)

A total of 829, 884 and 830 study participants had baseline measurements of vitamins A, D and E concentrations, respectively. The mean plasma vitamins A, D and E levels at baseline were 0.9 μmol/l (±0.3), 89.2 nmol/l (±31.0) and 9.8 μmol/l (±3.0), respectively. No significant correlations were observed between plasma vitamin D levels and season of blood draw (not shown).

Univariate correlates (P<0.20) of low vitamin A status (<0.7 μmol/l) are presented in Table 2. In the multivariate model (Table 2), risk of low vitamin A status was 36% lower per 10 μmol/l increase in vitamin E levels at baseline and 11% lower for every 25 nmol/l increase in vitamin D levels. Women with severe anemia (Hb <85 g/l) at baseline had a 47% higher risk of having low vitamin A status. Similarly, a 0.1 μg/ml increase in baseline selenium levels was associated with a 51% lower risk of low vitamin A status at baseline. The relationship of erythrocyte sedimentation rate (ESR) with low vitamin A status was nonlinear, with a sharp increase in risk of low vitamin A status at higher levels of ESR, after multivariate adjustment.

Table 2
Univariate (P<0.20) and multivariate (P≤0.05) correlates of low vitamin A (<0.7 μmol/l) status

Univariate correlates (P<0.20) of low vitamin D status (<80 nmol/l) are presented in Table 3. In multivariate analysis (Table 3), risk of low vitamin D status was 4% higher with each 100 cells per μl increase in CD8 cell counts, and 69% higher with a 10 μmol/l increase in baseline vitamin E levels. Women with elevated ESR at baseline (ESR >81 mm/h) had a 45% higher risk of having low vitamin D status. The risk was 13% lower with each 0.35 μmol/l increase in vitamin A levels. The relationship of low vitamin D status with gestational age at randomization remained nonlinear after multivariate adjustment; the risk of low vitamin D status decreased with increasing gestation until approximately 24 weeks and then increased again.

Table 3
Univariate (P<0.20) and multivariate correlates (P≤0.05) of low vitamin D status (<80 nmol/l)

Univariate (P<0.20) and multivariate-adjusted (P<0.05) correlates of low vitamin E status (<9.7 μmol/l) are presented in Table 4. A 16% lower risk of low vitamin E status was observed with every 1000 additional shillings spent per household on food daily (≈US$2 in 1995). Women who were enrolled earlier in the pregnancy (<16 weeks gestation) had a 23% higher risk of low vitamin E status. The nonlinear relationship of low vitamin E status with vitamin A levels at baseline remained after multivariate adjustment, with a sharp decrease in the risk of low vitamin E status observed once vitamin A levels reached ≈1.23 μmol/l.

Table 4
Univariate (P<0.20) and multivariate correlates (P≤0.05) of low vitamin E status (<9.7 μmol/l)

Discussion

In this study, we assessed the concentrations of lipid-soluble vitamins (A, D and E) and their correlates in HIV-infected pregnant women in Tanzania. Approximately 35, 39 and 51% of the women in the study had low vitamins A, D and E status, respectively.

The mean plasma vitamin A level was 0.9 μmol/l; this is similar to concentrations observed in HIV-infected pregnant women (22–35 weeks gestation) in Zimbabwe (0.87 μmol/l) (Friis et al., 2001). Another study in Zimbabwe also found similar vitamin A levels (0.98 μmol/l) in HIV-infected women, though these were measured postpartum (Zvandasara et al., 2006). HIV-infected individuals are expected to have lower concentrations of plasma vitamin A compared to HIV-uninfected individuals (Friis et al., 2001; Zvandasara et al., 2006). Vitamin A deficiency in pregnancy is also a major public health problem in HIV-uninfected pregnant women; about seven million pregnant women in developing countries are vitamin A deficient (West, 2002). The WHO states that vitamin A deficiency is a severe problem when the percentage of deficient subjects is >20%. In our study, the prevalence of vitamin A deficiency was 35%, which is similar to the prevalence reported in the study in Zimbabwe (Friis et al., 2001). The prevalence among HIV-infected nonpregnant women was 26% in a study in Kenya (Baeten et al., 2004); in contrast, the prevalence of vitamin A deficiency among presumably HIV-uninfected pregnant women was 26% in another study in Tanzania (Mulokozi et al., 2003) and 9% in Bangladesh (Ahmed et al., 2003), suggesting that the magnitude of this problem may be larger in HIV-infected women. Maternal vitamin A deficiency in HIV-uninfected women has been shown to increase risks of maternal morbidity and mortality (Christian et al., 2000) and compromise the vitamin A status of the breastfeeding infant (Fawzi et al., 1993; Allen, 2006).

We found that higher hemoglobin, vitamins D and E, and selenium concentrations were associated with decreased risk of low vitamin A levels. Several studies have observed an association between anemia and vitamin A status in presumably HIV-uninfected pregnant women, notably in Tanzania (Hinderaker et al., 2002) and Nepal (Bondevik et al., 2000). In a randomized trial in Indonesia, 97% of pregnant women supplemented with both vitamin A and iron became non-anemic, compared to 68% of those who received iron alone (Suharno et al., 1993). A possible explanation could be an impaired mobilization of iron from stores seen in vitamin A deficiency (Roodenburg et al., 1994). Vitamins A, D and E are lipid-soluble vitamins, and hence correlate with fat stores in the body; this might explain the relationship of vitamins D and E with risk of low vitamin A status.

ESR was related nonlinearly with greater risk of poor vitamin A status, at very high ESR levels. The nonlinear relationship with ESR and the increase in risk seen at higher ESR levels could indicate two potential mechanisms: first, in women with greater degree of inflammation, the vitamin A levels decline and they may not actually be deficient as the liver stores may be replete; and second, the women with poorer nutritional and vitamin A status are susceptible to greater inflammation and worse disease outcomes, compared to women with normal/high vitamin A status.

The main source of vitamin D is the synthesis in the skin catalyzed by ultraviolet-B solar radiation (Holick, 2004). Vitamin D inadequacy is not classically associated with equatorial regions, due to the abundance of perennial sunlight. Therefore, it was remarkable to observe approximately a 40% prevalence of vitamin D insufficiency (<80 nmol/l) in this cohort in Tanzania, only 6° from the Equator. The mean baseline vitamin D concentration was 89.18 nmol/l. Several studies have examined vitamin D concentrations in pregnant women in developed settings; a recent study in pregnant women in Pittsburgh (40° from the Equator) found that Caucasian women had a mean serum vitamin D concentration of 72.5 nmol/l (4–21 weeks gestation), compared to 40 nmol/l in African-American women (Bodnar et al., 2007). Approximately, 62% of Caucasian women and 96% of African-American women had vitamin D insufficiency. One recent study in the Gambia examined vitamin D levels in pregnant women in presumably HIV-uninfected pregnant women, and found only 20% of the women at insufficient levels at 20 weeks gestation (Prentice et al., 2009). The women included in this study, however, were mostly farmers who work outdoors for most of the day. The women in our study were recruited from a largely urban population in Dar es Salaam. Further, it may be possible that HIV infection itself may be responsible for the lower vitamin D levels observed in our study.

Low vitamin D status was associated with higher CD8 cell counts and ESR. This could suggest a possible role of vitamin D in inflammation. Although, the conventional role of CD8 cells is as cytotoxic cells, they also may be effector cells in inflammation (Babbe et al., 2000). The involvement of vitamin D in modulating CD8 cells is also indicated by the fact that CD8 cells express the highest concentration of vitamin D receptor of the immune cells (Veldman et al., 2000).

We also observed a nonlinear relationship of gestational age at randomization with risk of low vitamin D status; the study from Pittsburgh cited above conducted repeated analyses of vitamin D levels, at 4–21 and 37–42 weeks of gestation, and found that the vitamin D levels increased with gestational age (Bodnar et al., 2007). Though we did not conduct repeat measurements, the nonlinear relationship with gestational age suggested that women presenting later during pregnancy have higher levels of vitamin D.

The mean plasma vitamin E level in this cohort was 9.8 μmol/l; this is considerably lower compared to levels of 15 and 26 μmol/l in studies in Tanzania (Mulokozi et al., 2003) and Ethiopia (Wondmikun, 2005) among presumably HIV-uninfected pregnant or postpartum women. We found that risk of low vitamin E status was reduced with greater spending on food; this may be an indication of the fact that vitamin E-rich food sources, such as almonds, spinach and mangoes, are comparatively more expensive.

We also found that risk of low vitamin E status decreases with increasing gestational age. This is consistent with several previous studies (Knight et al., 1994). This increase in plasma vitamin E has been observed to parallel the rise in total lipid levels during pregnancy (Horwitt et al., 1972). The increased plasma vitamin E levels during pregnancy may be a result of the increase in the transport capacity for the vitamin in the plasma; β-lipoprotein is the major transport protein and is elevated as part of the hyperlipidemia associated with pregnancy (Haga et al., 1982). Therefore, this increase may not represent a true increase in the total tocopherol level.

Many of the benefits of the lipid-soluble vitamins are due to their involvement in the immune system. Vitamin A is important at all levels of the immune system (Villamor and Fawzi, 2005), including maintenance of epithelial integrity, acute-phase reactant in response to infection, monocyte differentiation and function, cytotoxicity of natural killer cells, antibody responses to tetanus toxoid (Semba et al., 1992) and measles vaccines (Coutsoudis et al., 1992), and total lymphocyte count (particularly CD4). Vitamin D increases phagocytic capacity of macrophages, number of natural killer cells and cell-mediated immunity, and is involved in the innate immune response (Bar-Shavit et al., 1981; Yang et al., 1993; Liu et al., 2006). Vitamin E is responsible for improving delayed type hypersensitivity skin response, increasing IL-2 production, neutrophil phagocytosis, lymphocyte proliferation and antibody response to T-cell-dependent vaccines, and reducing production of inflammatory cytokines such as TNF-α and IL-6 (Wang et al., 1995; Meydani et al., 1997).

The immunological benefit of these vitamins may assume greater importance in the context of HIV infection. Identification of women at increased risk of micronutrient deficiencies may help inform the design and implementation of targeted interventions for HIV-infected pregnant women in resource-poor settings.

Acknowledgements

We thank the mothers and children, and field teams, including physicians, nurses, midwives, supervisors, lab staff and the administrative staff, who made the study possible; and Muhimbili Medical Centre, Muhimbili University College of Health Sciences, and the National AIDS Control Program in Dar es Salaam for their institutional support. This study was supported by the National Institute of Child Health and Human Development (NICHD R01 32257), the Fogarty International Center (NIH D43 TW00004) and the Harvard School of Public Health.

Footnotes

Conflict of interest

The authors declare no conflict of interest.

References

  • Ahmed F, Mahmuda I, Sattar A, Akhtaruzzaman M. Anaemia and vitamin A deficiency in poor urban pregnant women of Bangladesh. Asia Pac J Clin Nutr. 2003;12:460–466. [PubMed]
  • Allen LH. Pregnancy and lactation. In: Bowman BA, Russell RM, editors. Present Knowledge in Nutrition. 9th edn. International Life Sciences Institute; Washington, DC: 2006. pp. 529–543.
  • Antelman G, Smith-Fawzi M, Kaaya S, Mbwambo J, Msamanga G, Hunter D, et al. Predictors of HIV-1 sero-status disclosure: a prospective study among HIV infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15:1865–1874. [PubMed]
  • Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med. 2000;192:393–404. [PMC free article] [PubMed]
  • Baeten JM, Richardson BA, Bankson DD, Wener MH, Kreiss JK, Lavreys L, et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr. 2004;79:218–225. [PubMed]
  • Bar-Shavit Z, Noff D, Edelstein S, Meyer M, Shibolet S, Goldman R. 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int. 1981;33:673–676. [PubMed]
  • Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137:447–452. [PubMed]
  • Bondevik GT, Eskeland B, Ulvik RJ, Ulstein M, Lie RT, Schneede J, et al. Anaemia in pregnancy: possible causes and risk factors in Nepali women. Eur J Clin Nutr. 2000;54:3–8. [PubMed]
  • Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:810–816. [PubMed]
  • Christian P, West KP, Jr, Khatry SK, Kimbrough-Pradhan E, LeClerq SC, Katz J, et al. Night blindness during pregnancy and subsequent mortality among women in Nepal: effects of vitamin A and beta-carotene supplementation. Am J Epidemiol. 2000;152:542–547. [PubMed]
  • Coutsoudis A, Kiepiela P, Coovadia HM, Broughton M. Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles. Pediatr Infect Dis J. 1992;11:203–209. [PubMed]
  • de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr. 2002;132:2895S–2901S. [PubMed]
  • Di Renzo GC, Clerici G, Neri I, Facchinetti F, Caserta G, Alberti A. Potential effects of nutrients on placental function and fetal growth. Nestle Nutr Workshop Ser Pediatr Program. 2005;55:73–81. discussion 81-72. [PubMed]
  • Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–561. [PubMed]
  • Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvita-min D3 on cytokine production by human decidual cells. Biol Reprod. 2006;75:816–822. [PubMed]
  • Fawzi W. Micronutrients and human immunodeficiency virus type 1 disease progression among adults and children. Clin Infect Dis. 2003;37(Suppl 2):S112–S116. [PubMed]
  • Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA. 1993;269:898–903. [PubMed]
  • Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, Hunter DJ. Rationale and design of the Tanzania vitamin and HIV infection trial. Control Clin Trials. 1999;20:75–90. [PubMed]
  • Friis H, Gomo E, Koestel P, Ndhlovu P, Nyazema N, Krarup H, et al. HIV and other predictors of serum beta-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr. 2001;73:1058–1065. [PubMed]
  • Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med. 2007;26:3735–3752. [PubMed]
  • Haga P, Ek J, Kran S. Plasma tocopherol levels and vitamin E/beta-lipoprotein relationships during pregnancy and in cord blood. Am J Clin Nutr. 1982;36:1200–1204. [PubMed]
  • Hinderaker SG, Olsen BE, Lie RT, Bergsjo PB, Gasheka P, Bondevik GT, et al. Anemia in pregnancy in rural Tanzania: associations with micronutrients status and infections. Eur J Clin Nutr. 2002;56:192–199. [PubMed]
  • Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S–1688S. [PubMed]
  • Horwitt MK, Harvey CC, Dahm CH, Jr, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci. 1972;203:223–236. [PubMed]
  • Keverenge-Ettyang GA, van Marken Lichtenbelt W, Esamai F, Saris W. Maternal nutritional status in pastoral versus farming communities of West Pokot, Kenya: differences in iron and vitamin A status and body composition. Food Nutr Bull. 2006;27:228–235. [PubMed]
  • Knight EM, Spurlock BG, Edwards CH, Johnson AA, Oyemade UJ, Cole OJ, et al. Biochemical profile of African American women during three trimesters of pregnancy and at delivery. J Nutr. 1994;124:943S–953S. [PubMed]
  • Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr. 2005;59:1250–1258. [PubMed]
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773. [PubMed]
  • Loeken MR. Free radicals and birth defects. J Matern Fetal Neonatal Med. 2004;15:6–14. [PubMed]
  • Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. 1997;277:1380–1386. [PubMed]
  • Miettinen O. Theoretical Epidemiology. Vol. 107. John Wiley & Sons; New York: 1985.
  • Mulokozi G, Lietz G, Svanberg U, Mugyabuso JK, Henry JC, Tomkins AM. Plasma levels of retinol, carotenoids, and tocopherols in relation to dietary pattern among pregnant Tanzanian women. Int J Vitam Nutr Res. 2003;73:323–333. [PubMed]
  • Picciano MF. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr. 2003;133:1997S–2002S. [PubMed]
  • Prentice A, Jarjou LMA, Goldberg GR, Bennett J, Cole TJ, Schoenmakers I. Maternal plasma 25-hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatr. 2009;98:1360–1362. [PMC free article] [PubMed]
  • Reichrath J, Querings K. Vitamin D deficiency during pregnancy: a risk factor not only for fetal growth and bone metabolism but also for correct development of the fetal immune system? Am J Clin Nutr. 2005;81:1177. author reply 1177-1178. [PubMed]
  • Roodenburg AJ, West CE, Yu S, Beynen AC. Comparison between time-dependent changes in iron metabolism of rats as induced by marginal deficiency of either vitamin A or iron. Br J Nutr. 1994;71:687–699. [PubMed]
  • Scholl TO, Chen X, Sims M, Stein TP. Vitamin E: maternal concentrations are associated with fetal growth. Am J Clin Nutr. 2006;84:1442–1448. [PMC free article] [PubMed]
  • Semba RD, Muhilal, Scott AL, Natadisastra G, Wirasasmita S, Mele L, et al. Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr. 1992;122:101–107. [PubMed]
  • Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr. 2004;80:1740S–1747S. [PubMed]
  • Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199–200. [PubMed]
  • Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia. 2000;43:1093–1098. [PubMed]
  • Stoltzfus RJ, Humphrey JH. Vitamin A and the nursing mother-infant dyad: evidence for intervention. Adv Exp Med Biol. 2002;503:39–47. [PubMed]
  • Suharno D, West CE, Muhilal, Karyadi D, Hautvast JG. Supplementation with vitamin A and iron for nutritional anaemiain pregnant women in West Java, Indonesia. Lancet. 1993;342:1325–1328. [PubMed]
  • Urassa W, Matunda S, Bredberg-Raden U, Mhalu F, Biberfeld G. Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin Diagn Virol. 1994;2:1–6. [PubMed]
  • Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374:334–338. [PubMed]
  • Villamor E, Fawzi WW. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev. 2005;18:446–464. [PMC free article] [PubMed]
  • Wang Y, Huang DS, Wood S, Watson RR. Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS. Immunopharmacology. 1995;29:225–233. [PubMed]
  • West KP., Jr Extent of vitamin A deficiency among preschool children and women of reproductive age. J Nutr. 2002;132:2857S–2866S. [PubMed]
  • WHO Proposed ‘World Health Organization staging system for HIV infection and disease’: preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS. 1993;7:711–718. [PubMed]
  • WHO Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organization; Geneva: 1995. p. 329. [PubMed]
  • Wondmikun Y. Lipid-soluble antioxidants status and some of its socio-economic determinants among pregnant Ethiopians at the third trimester. Public Health Nutr. 2005;8:582–587. [PubMed]
  • Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys. 1993;303:98–106. [PubMed]
  • Zaman Z, Fielden P, Frost PG. Simultaneous determination of vitamins A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects. Clin Chem. 1993;39:2229–2234. [PubMed]
  • Zvandasara P, Hargrove JW, Ntozini R, Chidawanyika H, Mutasa K, Iliff PJ, et al. Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation. J Acquir Immune Defic Syndr. 2006;43:107–116. [PubMed]